$14.25
0.080.56%
At Close: -
$14.25
00.00%
After Hours: 4:04 PM EDT
15 minutes delayed
Entrada Therapeutics
TRDANASDAQ
Entrada Therapeutics (TRDA) Forecast
NewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestOverview Rating
Speculative
Entrada Therapeutics (NASDAQ:TRDA) Stock Quotes, Forecast and News Summary
Entrada Therapeutics Stock (NASDAQ: TRDA) stock price, news, charts, stock research, profile.
| Open | $14.34 |
| Close | $14.25 |
| Volume / Avg. | 742.76K / 77.85K |
| Day Range | 13.98 - 14.52 |
| 52 Wk Range | 10.75 - 18.44 |
| Market Cap | $481.07M |
| P/E Ratio | 20.54 |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 44 |
| Short Interest | 8.49% |
| Days to Cover | 19.35 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
About Entrada Therapeutics Inc
Sector
Health Care
Industry
Biotechnology
Entrada Therapeutics Inc clinical-stage biopharmaceutical company aiming to transform the lives of p...
Show More
Compare
EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS better than industry
FAQ
How do I buy Entrada Therapeutics (TRDA) stock?
You can purchase shares of Entrada Therapeutics (NASDAQ:TRDA) through any online brokerage.
Who are Entrada Therapeutics (TRDA) competitors?
Other companies in Entrada Therapeutics’s space includes: KalVista Pharma (NASDAQ:KALV), Valneva (NASDAQ:VALN), Voyager Therapeutics (NASDAQ:VYGR), Larimar Therapeutics (NASDAQ:LRMR) and Replimune Group (NASDAQ:REPL).
What is the target price for Entrada Therapeutics (TRDA) stock?
There is no analysis for Entrada Therapeutics.
What is the forecast for Entrada Therapeutics (TRDA) stock?
Entrada Therapeutics has a consensus price target of $11.60.
Current stock price for Entrada Therapeutics (TRDA)?
The stock price for Entrada Therapeutics (NASDAQ: TRDA) is $14.25 last updated June 28, 2024 at 4:04 PM EDT.
Does Entrada Therapeutics (TRDA) pay a dividend?
There are no upcoming dividends for Entrada Therapeutics.
When is Entrada Therapeutics (NASDAQ:TRDA) reporting earnings?
Entrada Therapeutics’s Q2 earnings are confirmed for Tuesday, August 6, 2024.
Is Entrada Therapeutics (TRDA) going to split?
There is no upcoming split for Entrada Therapeutics.
What sector and industry does Entrada Therapeutics (TRDA) operate in?
Entrada Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.